Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ximena Elzo-Kraemer"'
Autor:
Danielle Delombaerde, Christof Vulsteke, Nico Van de Veire, Delphine Vervloet, Veronique Moerman, Lynn Van Calster, Anne-Marie Willems, Lieselot Croes, Félix Gremonprez, Astrid De Meulenaere, Ximena Elzo Kraemer, Kristien Wouters, Marc Peeters, Hans Prenen, Johan De Sutter
Publikováno v:
Pharmaceuticals, Vol 17, Iss 7, p 965 (2024)
Background: There is an unmet medical need for the early detection of immune checkpoint inhibitor (ICI)-induced cardiovascular (CV) adverse events due to a lack of adequate biomarkers. This study aimed to provide insights on the incidence of troponin
Externí odkaz:
https://doaj.org/article/5c2974b35ed74f08a578e0745f94e7c5
Autor:
Anne Deblander, Ellen Reynders, Lise-Marie Kinnaer, Hans Wildiers, Christof Vulsteke, Hannelore Denys, W. Wynendaele, Philip R. Debruyne, Ximena Elzo-Kraemer, Isabelle Spoormans, Ahmad Awada, Carrie Visser, Veronique Cocquyt, Andrea Gombos, Patrick Neven, Patrick Berteloot, Veerle Foulon, Sandra De Coster, Kevin Punie, Marleen Borms, Eric Strobbe
Publikováno v:
Cancer Research. 81:PS9-06
BackgroundEverolimus in combination with exemestane is indicated for the treatment of hormone receptor-positive, HER 2-neg endocrine resistant advanced breast cancer in postmenopausal women. This study investigated treatment adherence, tolerability,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66273f2886fe969972e95731b4f4714a
https://doi.org/10.1158/1538-7445.sabcs20-ps9-06
https://doi.org/10.1158/1538-7445.sabcs20-ps9-06
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.